AIMS: MiR126 was found to be frequently lost in many types of cancer, including malignant mesothelioma (MM), which represents one of the most challenging neoplastic diseases. In this study, we investigated the potential tumor suppressor function of MiR126 in MM cells. The effect of MiR126 was examined in response to oxidative stress, aberrant mitochondrial function induced by inhibition of complex I, mitochondrial DNA (mtDNA) depletion, and hypoxia. RESULTS: MiR126 was up-regulated by oxidative stress in nonmalignant mesothelial (Met5A) and MM (H28) cell lines. In Met5A cells, rotenone inhibited MiR126 expression, but mtDNA depletion and hypoxia up-regulated MiR126. However, these various stimuli suppressed the levels of MiR126 in H28 cells. MiR126 affected mitochondrial energy metabolism, reduced mitochondrial respiration, and promoted glycolysis in H28 cells. This metabolic shift, associated with insulin receptor substrate-1 (IRS1)-modulated ATP-citrate lyase deregulation, resulted in higher ATP and citrate production. These changes were linked to the down-regulation of IRS1 by ectopic MiR126, reducing Akt signaling and inhibiting cytosolic sequestration of Forkhead box O1 (FoxO1), which promoted the expression of genes involved in gluconeogenesis and oxidative stress defense. These metabolic changes induced hypoxia-inducible factor-1α (HIF1α) stabilization. Consequently, MiR126 suppressed the malignancy of MM cells in vitro, a notion corroborated by the failure of H28(MiR126) cells to form tumors in nude mice. INNOVATION AND CONCLUSION: MiR126 affects mitochondrial energy metabolism, resulting in MM tumor suppression. Since MM is a fatal neoplastic disease with a few therapeutic options, this finding is of potential translational importance.
AIMS: MiR126 was found to be frequently lost in many types of cancer, including malignant mesothelioma (MM), which represents one of the most challenging neoplastic diseases. In this study, we investigated the potential tumor suppressor function of MiR126 in MM cells. The effect of MiR126 was examined in response to oxidative stress, aberrant mitochondrial function induced by inhibition of complex I, mitochondrial DNA (mtDNA) depletion, and hypoxia. RESULTS:MiR126 was up-regulated by oxidative stress in nonmalignant mesothelial (Met5A) and MM (H28) cell lines. In Met5A cells, rotenone inhibited MiR126 expression, but mtDNA depletion and hypoxia up-regulated MiR126. However, these various stimuli suppressed the levels of MiR126 in H28 cells. MiR126 affected mitochondrial energy metabolism, reduced mitochondrial respiration, and promoted glycolysis in H28 cells. This metabolic shift, associated with insulin receptor substrate-1 (IRS1)-modulated ATP-citrate lyase deregulation, resulted in higher ATP and citrate production. These changes were linked to the down-regulation of IRS1 by ectopic MiR126, reducing Akt signaling and inhibiting cytosolic sequestration of Forkhead box O1 (FoxO1), which promoted the expression of genes involved in gluconeogenesis and oxidative stress defense. These metabolic changes induced hypoxia-inducible factor-1α (HIF1α) stabilization. Consequently, MiR126 suppressed the malignancy of MM cells in vitro, a notion corroborated by the failure of H28(MiR126) cells to form tumors in nude mice. INNOVATION AND CONCLUSION:MiR126 affects mitochondrial energy metabolism, resulting in MM tumor suppression. Since MM is a fatal neoplastic disease with a few therapeutic options, this finding is of potential translational importance.
Authors: Craig Ricci; Viktor Pastukh; Josh Leonard; Julio Turrens; Glenn Wilson; David Schaffer; Stephen W Schaffer Journal: Am J Physiol Cell Physiol Date: 2007-12-12 Impact factor: 4.249
Authors: Xiu-Fang Wang; Marc Birringer; Lan-Feng Dong; Pavel Veprek; Pauline Low; Emma Swettenham; Marina Stantic; Lin-Hong Yuan; Renata Zobalova; Kun Wu; Miroslav Ledvina; Stephen J Ralph; Jiri Neuzil Journal: Cancer Res Date: 2007-04-01 Impact factor: 12.701
Authors: Wenwei Zhang; Sandip Patil; Balwant Chauhan; Shaodong Guo; David R Powell; Jamie Le; Angelos Klotsas; Ryan Matika; Xiangshan Xiao; Roberta Franks; Kim A Heidenreich; Mini P Sajan; Robert V Farese; Donna Beer Stolz; Patrick Tso; Seung-Hoi Koo; Marc Montminy; Terry G Unterman Journal: J Biol Chem Date: 2006-02-21 Impact factor: 5.157
Authors: Xiaocheng C Dong; Kyle D Copps; Shaodong Guo; Yedan Li; Ramya Kollipara; Ronald A DePinho; Morris F White Journal: Cell Metab Date: 2008-07 Impact factor: 27.287
Authors: Sohail F Tavazoie; Claudio Alarcón; Thordur Oskarsson; David Padua; Qiongqing Wang; Paula D Bos; William L Gerald; Joan Massagué Journal: Nature Date: 2008-01-10 Impact factor: 49.962
Authors: Lan-Feng Dong; Emma Swettenham; Johanna Eliasson; Xiu-Fang Wang; Mikhal Gold; Yasmine Medunic; Marina Stantic; Pauline Low; Lubomir Prochazka; Paul K Witting; Jaroslav Turanek; Emmanuel T Akporiaye; Stephen J Ralph; Jiri Neuzil Journal: Cancer Res Date: 2007-12-15 Impact factor: 12.701
Authors: Ela Toxopeus; N Lynam-Lennon; K Biermann; G Dickens; P E de Ruiter; Jjb van Lanschot; J V Reynolds; Bpl Wijnhoven; J O'Sullivan; Ljw van der Laan Journal: Exp Biol Med (Maywood) Date: 2019-08-07
Authors: Alberto Izzotti; Stefano Carozzo; Alessandra Pulliero; Dinara Zhabayeva; Jean Louis Ravetti; Rakhmet Bersimbaev Journal: Am J Cancer Res Date: 2016-07-01 Impact factor: 6.166